Download PDF
1 / Pages

Other users also viewed these articles

Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial José Antonio Gimeno Orna; Ana Belén Mañas Martínez; Luis Rodríguez Padial; Manuel Anguita Sánchez; Vivencio Barrios; Javier Muñiz García; Antonio Pérez Pérez;
Endocrinol Diabetes Nutr. 2024;71:278-89
First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: A retrospective observational study (RETOSS-ENDO) Antonio Pérez Pérez; Emilio Ortega Martínez de Victoria; Francisco Arrieta Blanco; Assumpta Caixàs Pedragós; Estefanía Santos Mazo; Pablo Fernandez-Catalina; Sergio Martínez-Hervas; José Antonio López-Medina; Lorena Suárez-Gutiérrez; Juan Ramón Urgeles Planelles; Sònia Gatell Menchén; Francisco Tinahones Madueño;
Endocrinol Diabetes Nutr. 2022;69:540-2
Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19 Francisco Javier Carrasco-Sánchez; Enrique Carretero-Anibarro; Manuel Ángel Gargallo; Ricardo Gómez-Huelgas; Juan Francisco Merino-Torres; Domingo Orozco-Beltrán; Pedro José Pines Corrales; Manuel Antonio Ruiz Quintero;
Endocrinol Diabetes Nutr. 2022;69:209-18